| # | Drug | Count |
|---|---|---|
| 0 | DARUNAVIR | 3 |
| 1 | ETRAVIRINE | 3 |
| 2 | MARAVIROC | 3 |
| 3 | RILPIVIRINE HYDROCHLORIDE | 3 |
| 4 | LAMIVUDINE | 2 |
| 5 | NELFINAVIR MESYLATE | 2 |
| 6 | RITONAVIR | 2 |
| 7 | RITONAVIR 100 MG | 2 |
| 8 | ZIDOVUDINE | 2 |
| 9 | CALCITRIOL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MARAVIROC | 3 | 0.0013 |
| 1 | NELFINAVIR MESYLATE | 2 | 0.0010 |
| 2 | ETRAVIRINE | 3 | 0.0007 |
| 3 | ETELCALCETIDE | 1 | 0.0003 |
| 4 | DARUNAVIR | 3 | 0.0002 |
| 5 | LANTHANUM CARBONATE | 1 | 0.0002 |
| 6 | ZIDOVUDINE | 2 | 0.0002 |
| 7 | RITONAVIR 100 MG | 2 | 0.0001 |
| 8 | DOLUTEGRAVIR SODIUM | 1 | 0.0001 |
| 9 | LAMIVUDINE | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 3 | 0.0013 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 2 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 3 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 5 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Erythropoiesis-stimulating Agent [EPC] | 1 | 0.0000 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |